I'm surprised BDA continues to fly under the radar with so much going for it!
Along with the tiny MC relative to peers, they are in the handy position of already establishing relationships in the pharmacy space through the sales of their existing products.
While the revenue itself isn't a game changer, it is growing consistently quarter on quarter driven by expanding the footprint in the pharmacy space. With about 5.5K pharmacies in the country, they had grown to 760+ this year (as at last presentation). Half the sales are coming from pharmacy groups, and 40% from independent stores. This customer base takes time to grow, and having a head start with the current product range will be a valuable advantage when it comes time to launch new products.
BDA Price at posting:
33.5¢ Sentiment: Buy Disclosure: Held
